Pfizer has made a fortune off Viagra. No surprise to me because sex has always been a big, big business.
Here’s another sex-based investment opportunity. Japan’s Shionogi Inc. has developed a treatment for premature ejaculation. The product incorporates two local anesthetics in an aerosol applied to the tip of the penis and has shown to prolong intercourse by as much as five times.
Before you laugh, premature ejaculation is estimated to affect as many as a third of American men aged 18 to 59 years old.
Shionogi is traded in Japan (4507.JP) and on the U.S. pink sheets (SGIOF.PK).
Related Posts
- Meet the new Japanese Prime Minister (09/24/08)
- Japanese investors pour $ into mutual funds (05/27/09)
- Japan slides into recession (11/16/08)
- 35 Chinese firms make Fortune 500 list (07/10/08)
- Japan consumer spending still stuck in the do… (04/29/08)



{ 0 comments… add one now }